Increase in worldwide menopausal cases coupled with rise in awareness about post-menopausal signs and the available treatment options among women is expected to notably contribute toward the growth of the global market over next few years..
Increase in worldwide menopausal cases coupled with rise in awareness about post-menopausal signs and the available treatment options among women is expected to notably contribute toward the growth of the global market over next few years.
The global Hormone Replacement Therapy Market generated $31.06 billion in 2019, and is estimated to garner $46.50 billion by 2027, witnessing a CAGR of 5.1% from 2020 to 2027.
Increase in prevalence of menopausal disorder, rise in awareness regarding post-menopausal issues among women, and advent of novel hormone replacement therapies drive the growth of the global hormone replacement therapy market. North America contributed to the highest market share in terms of revenue in 2019, and will maintain its lead status during the forecast period. Fertility treatments and post menopause have been stopped during the pandemic.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/9873
Covid-19 scenario-
- Fertility treatments and post menopause have been stopped during the pandemic as there have been evidences that outlined that lesser estrogen levels posed more risks regarding the disease infection in older women. In addition, the hormone withdrawal may accelerate the progression of the virus in the bodies.
- Owing to lockdown and shift in focus toward prevention and treatment of corona-infected patients, many therapies have been postponed. However, the therapies would restart during the post-lockdown.
Hormone replacement therapy (HRT) involves the administration of synthetic estrogen hormone, human growth hormone, thyroid hormone, testosterone hormone, and progestogen hormone to replace depleting hormone levels of male and female and thus alleviate symptoms of menopause, hypothyroidism, male hypogonadism, and growth hormone deficiency.
The report offers detailed segmentation of the global hormone replacement therapy market based on therapy type, route of administration and region.
By therapy type, the estrogen hormone replacement therapy segment accounted for more than two-fifths of the total market share in 2019, and is estimated to maintain its leadership status by 2027. However, the human growth hormone replacement therapy segment is expected to manifest the highest CAGR of 7.1% from 2020 to 2027.
On the basis of route of administration, the market is segregated into oral, parenteral, and others. The oral segment dominated the market in 2019, and is anticipated to grow faster during the forecast period. This is attributed to increase in preference for oral HRT products and consumption accordingly. Furthermore, it enables few patients to reduce the need to visit clinics for treatments, thereby decreasing healthcare cost.
By region, North America contributed to the highest market share in terms of revenue in 2019, accounting for more than two-fifths of the global hormone replacement therapy market, and will maintain its lead status during the forecast period. On the other hand, Asia-Pacific would portray the fastest CAGR of 7.1% from 2020 to 2027.
Access Full Report: https://www.alliedmarketresearch.com/hormone-replacement-therapy-market-A09508
The Major Key Players Are:
Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.), Merck KGaA, Mylan N.V. (Viatris Inc.), Novartis International AG, Novo Nordisk A/S, and Pfizer Inc.
Trending Reports:
Healthcare Payer Solution Market - Global Opportunity Analysis and Industry Forecast, 2021–2030
Bioprocess Validation Market - Global Opportunity Analysis and Industry Forecast, 2021–2030
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch (dot) com